Nordberg, Björn
Mwangi, Winfred
van der Kop, Mia Liisa
Were, Edwin
Kaguiri, Eunice
Kågesten, Anna E.
Gabriel, Erin E.
Lester, Richard T.
Mwangi, Jonathan
Ekström, Anna Mia
Rautiainen, Susanne
Funding for this research was provided by:
Stiftelsen Läkare mot AIDS Forskningsfond (FOa2017-0006)
Stig och Ragna Gorthons stiftelse (2020-2656)
European and Developing Countries Clinical Trials Partnership (1104 EACCR2 EDCTP-RegNet2015)
Karolinska Institute
Article History
Received: 6 April 2021
Accepted: 20 October 2021
First Online: 22 November 2021
Competing interests
: This study uses a technology platform (WelTel/SMS) that was developed by a non-profit organisation and a private company. One co-author, Richard T. Lester, has financial and professional interests in both organisations. Richard T. Lester reports competing interests from his involvement in the WelTel International mHealth Society and WelTel Inc, grants from National Institutes of Health (NIH), Canadian Institutes of Health Research (CIHR), BC Lung Association, British Columbia Centre for Disease Control Foundation, and Grand Challenges Canada, and non-financial support from WHO and Task Force on Digital Health for TB Control, outside the submitted work. All other authors declare that they have no competing interests.